newsfilter
← Latest News
Business Wire·

Cyteir Therapeutics Selected to Join Russell 2000® Index

Cyteir Therapeutics, Inc. ("Cyteir") (NASDAQ:CYT), a company focused on the discovery and development of next-generation synthetically lethal therapies for cancer was added as a member of the U.S. small-cap Russell 2000® Index, effective after the US m